{"created":"2015-05-14T14:35:01+00:00","modified":"2015-05-14T14:35:02+00:00","valid":{"from":"2013-01-02T11:02:21+00:00","to":"3013-01-02T11:02:21+00:00"},"hreflang":"en","guid":"99cdad08-4b8b-48c7-8e69-56d8a7520638","contenttemplated":"[{\"type\":\"text/html\",\"content\":\"<p>In the coming weeks, pharmaceutical giant Pfizer is expected to launch a $4 billion stock offering for Zoetis -- its animal health division. The news underscores just how lucrative drugs and vaccines for animals have become.</p>\"},{\"type\":\"text/html\",\"content\":\"<p>You can see the financial opportunities at veterinarians offices around the country, like the Ft. Washington Veterinary Hospital in suburban Philadelphia co-owned by Jeffery Berman.</p>\"},{\"content\":\"<p>Berman, who provides services such as acupuncture and experimental stem cell treatment, says people spend on their pets.</p>\",\"type\":\"text/html\"},{\"type\":\"text/html\",\"content\":\"<p>“I mean, I’ve had people do second mortgages on their homes for animals. I know some who have spent upwards of $60,000 on their pets,” he says.</p>\"},{\"type\":\"text/html\",\"content\":\"<p>Businesses, including the pharmaceutical industry, are watching human behavior and responding. Companies like Novartis and Pfizer release new heartworm drugs, painkillers and vaccines each year and they’re getting scooped up.</p>\"},{\"content\":\"<p>“If you were to look at the world-wide market, you are looking in the neighborhood of $20 billion in annual sales,” says Damien Conover, director of pharmaceutical research at Morningstar. Conover projects the animal drug business to grow at a “moderate” pace – 5 percent - over the next five years.</p>\",\"type\":\"text/html\"},{\"content\":\"<p>That’s not just because people go to the bank to take care of Frisky. A growing demand for meat puts a higher premium on medicine to keep livestock and poultry healthy.</p>\",\"type\":\"text/html\"}]","published":"2013-01-02T11:02:21+00:00","itags":["Marketplace","Marketplace Morning Report for Wednesday, January 2, 2013","PMP:Marketplace_PMP","Marketplace Morning Report","99cdad084b8b8c75e69656d8a7520638"],"description":"Demand for animal drugs is rising amongst pet owners and livestock and poultry farmers.","title":"Pfizer to spin off animal pharmaceuticals","byline":"D Gorenstein","teaser":"Demand for animal drugs is rising amongst pet owners and livestock and poultry farmers.","tags":["veterinarian","poultry","APM","Business","livestock","pets","pharmaceuticals"],"contentencoded":"<div class=\"barn-cleaned\"><p>In the coming weeks, pharmaceutical giant Pfizer is expected to launch a $4 billion stock offering for Zoetis -- its animal health division. The news underscores just how lucrative drugs and vaccines for animals have become.</p>\n<p>You can see the financial opportunities at veterinarians offices around the country, like the Ft. Washington Veterinary Hospital in suburban Philadelphia co-owned by Jeffery Berman.</p>\n<p>Berman, who provides services such as acupuncture and experimental stem cell treatment, says people spend on their pets.</p>\n<p>“I mean, I’ve had people do second mortgages on their homes for animals. I know some who have spent upwards of $60,000 on their pets,” he says.</p>\n<p>Businesses, including the pharmaceutical industry, are watching human behavior and responding. Companies like Novartis and Pfizer release new heartworm drugs, painkillers and vaccines each year and they’re getting scooped up.</p>\n<p>“If you were to look at the world-wide market, you are looking in the neighborhood of $20 billion in annual sales,” says Damien Conover, director of pharmaceutical research at Morningstar. Conover projects the animal drug business to grow at a “moderate” pace – 5 percent - over the next five years.</p>\n<p>That’s not just because people go to the bank to take care of Frisky. A growing demand for meat puts a higher premium on medicine to keep livestock and poultry healthy.</p></div>","audio":[{"type":"image/jpeg","meta":{"width":"610","crop":"primary","height":"340"},"href":"http://www.marketplace.org/sites/default/files/styles/primary-image-610x340/public/155478120.jpg?itok=KcH83f_V"},{"href":"http://play.publicradio.org/pmp/d/podcast/marketplace/segments/2013/01/02/marketplace_segment03_20130102_64.mp3","format":"MP3","type":"audio/mpeg","meta":{"duration_hms":"00:01:40","duration":100,"api":{"type":"application/json","href":"http://api.publicradio.org/audio/v2?ref=pmp&id=apm-audio:/marketplace/segments/2013/01/02/marketplace_segment03_20130102"}}}]}